Back to results
US 9,427,420 B2Granted
Acamprosate formulations, methods of using the same, and combinations comprising the same
AssigneeSynchroneuron, LLC
InventorsBarry S. Fogel, William D. Kerns, Kei-Lai Fong, San-Laung Chow, Edward Lin, David Wong
Life of this patent
Estimating the term…
Abstract
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
Claims4
A method comprising a step of:
- administering to a subject a tablet comprising:
- 800 mg of acamprosate calcium or other pharmaceutically acceptable salt of acamprosate, distributed within a polymer matrix that comprises or consists of
- 60 mg of carbomer homopolymer type B, which tablet further comprises
- a neuroleptic.
1 more element
The method of 2, wherein the neuropsychiatric disorder is tardive dyskinesia.
A tablet comprising:
- 800 mg acamprosate calcium or other pharmaceutically acceptable salt of acamprosate, distributed within a polymer matrix that comprises or consists of:
- 60 mg of carbomer homopolymer type B, which tablet further comprises a neuroleptic.
Dependencies are inferred from the claim text.